SCNI
Scinai Immunotherapeutics
SCNI
SCNI
18 hedge funds and large institutions have $1.08M invested in Scinai Immunotherapeutics in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+5
Holders Change %
+38.46%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
1
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
HF
HRT Financial
New York
|
$121K |
2 |
Citadel Advisors
Miami,
Florida
|
$111K |
3 |
Goldman Sachs
New York
|
$103K |
4 |
VF
Virtu Financial
New York
|
$70K |
5 |
TPWA
TRUE Private Wealth Advisors
Salem,
Oregon
|
$46K |
Top Sellers
1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
$37K |
2 |
Two Sigma Investments
New York
|
$0 |
3 |
Morgan Stanley
New York
|
$157K |
4 |
Wells Fargo
San Francisco,
California
|
$3K |